An observational study in Lung Cancer, sponsored by Dartmouth-Hitchcock Medical Center. Suspended at 1 site in United States. Open to participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-09-08.
Sponsored by Dartmouth-Hitchcock Medical Center · Observational
The purpose of this study is to research patient preferences for lung cancer screening and pilot mobile units to address the barrier of access that decreases participation in lung cancer screening.
The overarching goal of this study is to research patient preferences for lung cancer screening and pilot mobile units to address the barrier of access that decreases participation in lung cancer screening. To facilitate this, the investigators will evaluate the feasibility of mobile lung cancer screening clinics to improve access through focus group study in designated rural areas of New Hampshire and Vermont, canvas and survey these areas to confirm need, and pilot the mobile lung cancer screening clinic to establish practicability. Findings from the proposed project will be used as preliminary data to apply for further funding and to implement the mobile unit in these identified rural communities on a consistent basis.
7,243 studies on the registry are indexed under Lung Neoplasms; 1,557 are open to participants now.
This study's planned enrollment of 320 is above the median of 189 across 1,514 observational studies indexed under Lung Neoplasms.
Browse Lung Neoplasms studies →Dartmouth-Hitchcock Medical Center is the lead sponsor of 472 studies on the registry; 68 are open to participants now.
Of its 30 completed or terminated interventional studies of FDA-regulated products, 20 (67%) have results posted.
Counted across the registry records on this site, refreshed daily.
The individuals that will be included in this study will be those that meet lung cancer screening eligibility.
Exclusion Criteria:
-
Focus groups will be conducted in 2 New Hampshire and 2 Vermont towns to better understand patient knowledge, attitudes, and preferences regarding access to lung cancer screening.
Based on focus group feedback, the investigators will visit each proposed site to survey on 2 separate dates to confirm days and times of high traffic. The investigators will also survey patrons at the proposed locations to further determine prospective patient mobile screening preferences and evaluate willingness to participate in screening.
The investigators will pilot mobile lung cancer screening clinics at each chosen location using the knowledge acquired from focus group experience and local patient survey. Surveys will be conducted at these clinics, and patients will be followed for up to 5 years.
Recruitment
Number of individuals recruited to the mobile lung cancer screening units
Time frame: 6 months after starting the mobile lung cancer screening units (Aim 3)
Change in knowledge
Change in knowledge before and after entering the mobile lung cancer screening, as determined by the pre and post survey
Time frame: 6 months after starting the mobile lung cancer screening units (Aim 3)
Plan to share: No
This study is suspended, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dartmouth-Hitchcock Medical Center